Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Natera Shares Jump 21% on Strong Demand for Cancer Blood Test

Summary by TFD
Genomics company Natera's stock gained 21% on Friday following strong demand for its blood test for detecting cancer, in a move that made executive chairman and co-founder Matthew Rabinowitz a billionaire
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

TFDTFD

Natera Shares Jump 21% on Strong Demand for Cancer Blood Test

Genomics company Natera's stock gained 21% on Friday following strong demand for its blood test for detecting cancer, in a move that made executive chairman and co-founder Matthew Rabinowitz a billionaire

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

TFD broke the news on Monday, August 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer icon

Cancer

Stock Markets icon

Stock Markets

San Carlos icon

San Carlos

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal